No Data
Sino Medical: Plans to Repurchase Shares Worth 15 Million to 30 Million Yuan for Employee Incentives
Gelonghui reported on March 13 that Sino Medical announced its plan to repurchase shares through centralized bidding. The total repurchase amount will be no less than 15 million yuan and no more than 30 million yuan, including a special loan of up to 27 million yuan. The repurchase price will not exceed 35.10 yuan per share, and the program will run from March 13, 2026, to March 12, 2027. The repurchased shares are intended for employee stock ownership plans or equity incentives. If these purposes are not implemented within the specified period, any untransferred shares will be canceled. Additionally, the company’s directors, supervisors, senior management, controlling shareholders, and others have no plans to reduce their holdings in the next six months. This repurchase carries risks related to price fluctuations, funding availability, and policy changes.
Little K Morning News | NVIDIA's Q4 revenue surged 75%, SK Hynix plans to invest $15 billion to expand chip production capacity.
The main content of today's STAR Market morning report includes: ① Guangzhou proposes to deepen 'Artificial Intelligence+' and launch an initiative to significantly increase computing power; ② Meizu mobile phones may become history, with operations substantially halted and formal delisting in March; ③ Hygon Information reports a 31.66% year-on-year increase in net profit for 2025; ④ Zhiyang Innovation terminates planning for a major asset restructuring, and its stock resumes trading.
Sino Medical: Announcement on the 2025 Annual Performance Quick Report of Sino Medical Science and Technology Co., Ltd.
Announcement on the 2025 Preliminary Performance Report of Seno Medical Science and Technology Co., Ltd.
Express News | Sino Medical: Net profit increased by 3,057.05% year-on-year in 2025
Express News | Sino Medical: Plans to repurchase company shares for 15 million to 30 million yuan